Lindahl advises Dicot Pharma AB on rights issue
Lindahl is acting as legal adviser to Dicot Pharma AB (publ) in connection with a rights issue of units amounting to approximately SEK 122.6 million.
The rights issue relates to units consisting of shares and warrants. Provided that the issue is fully subscribed for, Dicot Pharma will receive proceeds of approximately SEK 122.6 million. The Company has received subscription commitments and guarantee commitments amounting to approximately SEK 79.8 million, corresponding to approximately 65 percent of the rights issue.
Dicot Pharma is a pharmaceutical company that is developing the candidate LIB-01 into a new modern potency drug. Dicot's main strategy is to develop LIB-01 in-house, up to and including a clinical phase 2a study and thereafter, in partnership with larger, established pharmaceutical companies, finance and develop LIB-01 further into a registered drug for the world market. The company's shares are listed on the Spotlight Stock Market.
Lindahl's team consists of Mattias Prage, Michaela Larsson and Olle Swärd Brattström.
Do you want to know more? Contact:
Mattias Prage
Partner | AdvokatMichaela Larsson
Associate | AdvokatOlle Swärd Brattström
AssociateCarousel items
-
Cases and transactions
7/13/2026
Lindahl Advises Bokusgruppen AB (publ) on the Acquisition of Pen Store Sthlm AB
Lindahl has advised Bokusgruppen on its acquisition of Pen Store, the leading Nordic retailer of pens and artists' materials serving customers across the EU.
-
News articles
7/7/2026
Lindahl included among Sweden's ten most reputable patent firms for the second consecutive year
For the second consecutive year, Lindahl has been named among Sweden's ten most reputable patent law firms by The Patent Lawyer Magazine – a testament to the firm's strong expertise and long-term commitment in intellectual property law.
-
Portraits
7/3/2026
Jesper on business-oriented legal advice in energy: "It is not enough for the advice to be correct"
Lindahl's energy team is recognised in Legal 500 for combining deep regulatory expertise with broad commercial legal experience – find out how they support clients in a rapidly evolving sector.
-
Knowledge
6/29/2026
The scope of the Swedish FDI Act is expanded – is your business affected?
MCF's new regulation (MCFFS 2026:13) expands the scope of the Swedish FDI Act from 15 July 2026. Is your business affected? Read about the key changes.
-
Read more news and insights?
